Literature DB >> 861128

The effect of dipyridamole on platelet function: correlation with blood levels in man.

S M Rajah, M J Crow, A F Penny, R Ahmad, D A Watson.   

Abstract

1 The effect on platelet functions of dipyridamole (a pyrimido-pyrimidine compound) was compared with a control group of patients taking warfarin. 2 Adhesion, aggregation and platelet factor 4 availability showed a significant decrease in the dypyridamole group. 3 Aggregation and platelet factor 4 showed a significant correlation with blood dipyridamole level. 4 Adhesion, aggregation and platelet factor 4 were reduced below the lower limit of normal at blood dipyridamole levels above 3.5 micronmol/1.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861128      PMCID: PMC1429003          DOI: 10.1111/j.1365-2125.1977.tb00683.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism.

Authors:  S M Manohitharajah; A N Rahman; R J Donnelly; P B Deverall; D A Watson
Journal:  Thorax       Date:  1974-11       Impact factor: 9.139

3.  Platelet and fibrinogen consumption in man.

Authors:  L A Harker; S J Slichter
Journal:  N Engl J Med       Date:  1972-11-16       Impact factor: 91.245

4.  The effect on dipyridamole on platelet aggregation and adhesiveness.

Authors:  G R Gray; P A Wilson; A S Douglas
Journal:  Scott Med J       Date:  1968-12       Impact factor: 0.729

Review 5.  Rôle of platelets in thrombosis.

Authors:  J F Mustard; L Jorgensen; T Hovig; M F Glynn; H C Rowsell
Journal:  Thromb Diath Haemorrh Suppl       Date:  1966

6.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

7.  Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit.

Authors:  P R Emmons; M J Harrison; A J Honour; J R Mitchell
Journal:  Nature       Date:  1965-10-16       Impact factor: 49.962

  7 in total
  11 in total

1.  Dipyridamole: pharmacokinetics and effects on aspects of platelet function in man.

Authors:  D Gregov; A Jenkins; E Duncan; D Siebert; S Rodgers; B Duncan; F Bochner; J Lloyd
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

2.  Thrombocytosis in rheumatoid arthritis.

Authors:  S M Rajah
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

3.  Anticoagulants and the Björk-Shiley prosthesis.

Authors:  S M Rajah; S Rao; D A Watson
Journal:  Br Heart J       Date:  1979-09

Review 4.  Prophylaxis of venous thromboembolism.

Authors:  V V Kakkar; M D Stringer
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

5.  Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.

Authors:  D J Crutchley; U S Ryan; J W Ryan
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

Review 6.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

7.  Dipyridamole treatment in chronic obstructive airways disease: effect on platelet regeneration time.

Authors:  E Tremoli; L Bertoli; R Merlini; S Colli; P Maderna; O Mantero; C R Sirtori
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Antiplatelet drugs: clinical pharmacology and therapeutic use.

Authors:  A S Gallus
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

9.  The interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.

Authors:  S M Rajah; A F Penny; M J Crow; M D Pepper; D A Watson
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

10.  Enhanced prostacyclin production by dipyridamole in man.

Authors:  G G Neri Serneri; G Masotti; L Poggesi; G Galanti; A Morettini
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.